Acasti Pharma Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript
All right. Hello, everyone, and thank you all for joining us during the Lytham Partners Spring 2023 Investor Conference. My name is Robert Blum, Managing Partner of Lytham Partners. During this fireside chat, we welcome Acasti Pharma, ticker symbol of ACST on the Nasdaq, and their CEO, Prashant Kohli. (Conference Instructions)
So with that, let's begin. Prashant, welcome.
Thank you, Robert. I really appreciate the opportunity and look forward to connecting with the audience and you.
Questions & Answers
Fantastic. Before we begin, just a little bit of background on yourself here.
Yeah, happy to do that, Robert. So I have 20-plus years in the industry. I started my journey on the drug commercialization side, specifically new product launch strategies, end-to-end; defining the value
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |